Altnia is a privately-held biotechnology incubator and life sciences R&D company based in Melbourne Australia. Our aim is to accelerate the solutions to medical problems impacting people around the world. Our team has expertise in regenerative medicine, drug discovery, medical devices, biologics manufacture, cellular therapy and acellular (cell-free) therapies. We have co-invented of the underlying technologies in Exopharm, Genscreen, Cardio Therapeutics (acquired by NYRADA in 2017). We have also co-founded clinical-stage Cynata Inc (now Cynata Therapeutics Ltd ASX-CYP).